What is the clinical role of this ophthalmic combination?

This product pairs an aminoglycoside antibiotic with a corticosteroid in a single ophthalmic suspension for topical ocular use. Clinics may consider it when inflammation is present and bacterial involvement is a concern, such as after anterior segment procedures or with corneal surface irritation. Selection is based on clinician judgment, local protocols, and labeling. It is not a stand‑alone solution for every eye condition, and it should be used under the direction of a licensed prescriber.

How is the product supplied for clinic use?

It is provided as a multi‑dose 5 mL ophthalmic suspension in a dropper bottle. The listing denotes a Non‑English packaging presentation; ensure staff have access to translated instructions where needed. Manufacturer lot and expiry appear on the packaging. Review the container and carton for the most current composition, handling guidance, and safety information before adding to procedure kits or med carts.

Where does this fit within postoperative eye‑care workflows?

Many ophthalmology services incorporate an antibiotic‑steroid ophthalmic suspension into perioperative protocols when coverage for inflammation and potential bacterial contamination is desired. It may be included in cataract or anterior segment kits for standardized pathways. Use parameters, duration, and follow‑up schedules are determined by the prescriber and the facility’s policy. Ensure technicians and nursing staff are trained in handling precautions and counseling points consistent with the label.

What precautions should clinics consider with preservatives and lenses?

The formulation contains a quaternary ammonium preservative (benzalkonium chloride). Preservatives can interact with soft contact lenses. Many clinics advise against wearing contact lenses during active treatment with preserved drops unless directed otherwise by the prescriber. Confirm label instructions and clinic policy, and provide consistent counseling across staff. For sensitive patients, discuss whether a preservative‑free alternative is appropriate for the clinical situation.

What adverse effects and monitoring are relevant in practice?

Reported ocular effects may include transient burning or stinging, eye pain, irritation, and increases in intraocular pressure, particularly in steroid responders. Encourage patients to report vision changes, persistent discomfort, or worsening symptoms promptly. Follow the prescriber’s monitoring plan, which may include pressure checks during steroid use. Review contraindications and cautions on the package insert before adding to packs or initiating therapy within established protocols.

Do you offer alternatives or generics for formulary flexibility?

Availability varies. Some clinics consider generic tobramycin dexamethasone eye drops or alternate branded combinations when permitted by policy and payer rules. Confirm therapeutic intent, labeling, and prescriber preferences before substitution. If an English‑language carton is required, contact the team to confirm current options from the catalog and align with your facility’s formulary requirements.

How should facilities approach storage and handling?

Follow the manufacturer’s label for storage and handling requirements. Keep the bottle closed when not in use, avoid touching the dropper tip, and maintain clean technique when adding to procedure kits. Check expiry dates during inventory cycles, and segregate incoming lots for traceability. If clinic policy requires additional labeling or translated instructions for Non‑English cartons, apply those measures before placement in med carts or postoperative packs.

You must be logged in to add items to the cart.

Tobradex® Ophthalmic Suspension 0.3%, 0.1% (Non-English)

Tobradex® Ophthalmic Suspension for Clinics

Name: Tobradex® Ophthalmic Suspension – Professional Clinic Supply
SKU: 88806
Price: 20.99 USD
Availability: InStock

Prescription Medication

$20.99

Description

This ophthalmic suspension combines an aminoglycoside antibiotic with a corticosteroid for short-term management of ocular inflammation where bacterial involvement is a concern. It supports perioperative eye care and acute surface injuries under clinician supervision. Facilities stock it to standardize kits for cataract and anterior segment workflows, as well as to equip urgent eye care. Available through US distribution to streamline procurement for licensed practices.

What Tobradex Is and How It Works

Tobradex® is a prescription, sterile ophthalmic suspension for topical ocular use. It pairs tobramycin, an aminoglycoside, with dexamethasone, a corticosteroid, in a single bottle. Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors.

As a Tobramycin/Dexamethasone ophthalmic suspension, this preparation may be considered when inflammation coexists with suspected bacterial contamination of the conjunctiva or cornea. The antibiotic component helps cover common gram-positive and gram-negative organisms encountered in outpatient ophthalmology. The steroid component modulates inflammatory pathways that drive redness and swelling. Selection, initiation, and duration remain at the prescriber’s discretion and per facility policy.

It is intended for topical administration to the eye. For category planning and related therapies, see Ophthalmology.

Professional Applications

Clinics integrate this preparation across several ophthalmic workflows. It can fit post-operative care after cataract procedures, anterior segment interventions, and corneal surface care when dual-class coverage is indicated. Practices may include tobramycin dexamethasone eye drops in standardized post-op kits to support consistent care pathways. Urgent care rooms and on-call carts can also carry this option for ocular surface triage.

For protocol development and education, review in-house guidance alongside practical primers such as our Ophthalmic Overview. Retina programs may reference Vision Disorders and Eylea HD for broader context across eye care. For cross-department formulary planning, browse Pharmaceuticals.

Key Features

Dual-class composition: antibiotic and corticosteroid in one bottle.
Sterile ophthalmic suspension: designed for topical ocular use.
Preserved formulation: includes benzalkonium chloride.
Clinic-ready sizing: compact 5 mL presentation.
Non-English packaging: verify language support for staff.
Label clarity: manufacturer lot and expiry on packaging.
Workflow alignment: suitable for post-op kits and triage.

Benefits in Practice

This product helps simplify postoperative and acute-care regimens by combining two pharmacologic classes into a single bottle. Fewer SKUs can reduce reordering steps and streamline training. The compact container fits medication drawers, med carts, and pre-assembled procedure trays. Consistent composition supports standardized perioperative protocols across multi-site practices.

Operational efficiency also extends to counseling. Teams can address handling precautions once rather than for separate antibiotic and steroid products. Routine monitoring remains important where steroids are used; steroid responders may require intraocular pressure checks per clinic policy. Reported reactions can include eye irritation, transient discomfort, and pressure elevations. Avoid contact lens wear during active treatment with preserved drops unless directed by the prescriber.

Composition & Ingredients

Tobramycin Dexamethasone eye drops 0.3%/0.1% are supplied as an ophthalmic suspension for topical use under licensed supervision. The tobramycin component belongs to the aminoglycoside class, while dexamethasone is a corticosteroid. This tobramycin dexamethasone combination is widely familiar to eye-care teams.

Active: tobramycin — aminoglycoside antibiotic.
Active: dexamethasone — corticosteroid anti-inflammatory.
Excipients: benzalkonium chloride, sodium chloride, hydroxyethyl cellulose, water for injection.

Inactive components may vary slightly by market presentation. Always review the immediate container and carton labeling to confirm excipients and usage instructions prior to clinic deployment.

Packaging & Supply

Supplied in a 5 mL multi-dose bottle suitable for clinic use. The listing reflects a Non-English packaging presentation; ensure staff have access to translated instructions where required by policy. For formulary accuracy and inventory labeling, the packaging displays the product identity and manufacturer lot and expiry. Tobradex Ophthalmic Suspension 0.3%/0.1% is available to verified buyers. Clinics seeking additional detail may confirm carton language and codes before ordering. The tobramycin with dexamethasone suspension format supports efficient stocking for ophthalmology workflows.

Ordering & Logistics

Licensed facilities can request account verification to view live availability and volume tiers. Sign in to access contract pricing, submit purchase orders, and add items to procurement lists. Our team can coordinate documentation such as label images upon request when available. For centralized buying, integrate this SKU into your facility’s standard ophthalmic set. Authorized purchasers may also Buy Tobramycin Dexamethasone drops through their account portal once verification is complete.

Comparable Products

Depending on clinical focus, clinics may also maintain complementary ophthalmic agents. For glaucoma protocols, see Lumigan. Retina programs may utilize anti-VEGF therapies such as Eylea. Always confirm indications, dosing routes, and labeling differences before substitution or combined use within a care pathway.

Pricing & Access

Sign in for pricing visibility and available contract tiers suited to clinic purchasing. Options may include multi-unit packaging, purchase orders, and scheduled replenishment per account status. Qualified buyers can Buy Tobradex Ophthalmic Suspension through the verified portal to integrate with existing procurement workflows.

Availability & Substitutions

Supply can vary by lot and market presentation. If a particular packaging language or batch configuration is needed, confirm details prior to purchase. Where institutional policy allows, some facilities may consider Generic tobramycin dexamethasone eye drops as a formulary alternative. Review prescriber preferences, labeling, and state requirements before any substitution. No restock timelines are guaranteed; confirm near-term needs against current on-hand inventory.

Authoritative Sources

Manufacturer’s prescribing information and carton labeling for the ophthalmic combination.
U.S. FDA resources on ophthalmic antibiotics and corticosteroid combinations.
American Academy of Ophthalmology guidance on topical ocular therapies and monitoring.

Ready to align your ophthalmic formulary? Sign in to request allocation with temperature-controlled handling when required and tracked US delivery.

Frequently Asked Questions

What is the clinical role of this ophthalmic combination?
This product pairs an aminoglycoside antibiotic with a corticosteroid in a single ophthalmic suspension for topical ocular use. Clinics may consider it when inflammation is present and bacterial involvement is a concern, such as after anterior segment procedures or with corneal surface irritation. Selection is based on clinician judgment, local protocols, and labeling. It is not a stand‑alone solution for every eye condition, and it should be used under the direction of a licensed prescriber.
How is the product supplied for clinic use?
It is provided as a multi‑dose 5 mL ophthalmic suspension in a dropper bottle. The listing denotes a Non‑English packaging presentation; ensure staff have access to translated instructions where needed. Manufacturer lot and expiry appear on the packaging. Review the container and carton for the most current composition, handling guidance, and safety information before adding to procedure kits or med carts.
Where does this fit within postoperative eye‑care workflows?
Many ophthalmology services incorporate an antibiotic‑steroid ophthalmic suspension into perioperative protocols when coverage for inflammation and potential bacterial contamination is desired. It may be included in cataract or anterior segment kits for standardized pathways. Use parameters, duration, and follow‑up schedules are determined by the prescriber and the facility’s policy. Ensure technicians and nursing staff are trained in handling precautions and counseling points consistent with the label.
What precautions should clinics consider with preservatives and lenses?
The formulation contains a quaternary ammonium preservative (benzalkonium chloride). Preservatives can interact with soft contact lenses. Many clinics advise against wearing contact lenses during active treatment with preserved drops unless directed otherwise by the prescriber. Confirm label instructions and clinic policy, and provide consistent counseling across staff. For sensitive patients, discuss whether a preservative‑free alternative is appropriate for the clinical situation.
What adverse effects and monitoring are relevant in practice?
Reported ocular effects may include transient burning or stinging, eye pain, irritation, and increases in intraocular pressure, particularly in steroid responders. Encourage patients to report vision changes, persistent discomfort, or worsening symptoms promptly. Follow the prescriber’s monitoring plan, which may include pressure checks during steroid use. Review contraindications and cautions on the package insert before adding to packs or initiating therapy within established protocols.
Do you offer alternatives or generics for formulary flexibility?
Availability varies. Some clinics consider generic tobramycin dexamethasone eye drops or alternate branded combinations when permitted by policy and payer rules. Confirm therapeutic intent, labeling, and prescriber preferences before substitution. If an English‑language carton is required, contact the team to confirm current options from the catalog and align with your facility’s formulary requirements.
How should facilities approach storage and handling?
Follow the manufacturer’s label for storage and handling requirements. Keep the bottle closed when not in use, avoid touching the dropper tip, and maintain clean technique when adding to procedure kits. Check expiry dates during inventory cycles, and segregate incoming lots for traceability. If clinic policy requires additional labeling or translated instructions for Non‑English cartons, apply those measures before placement in med carts or postoperative packs.

Specifications

Main Ingredient:
Manufacturer: Novartis
Drug Class:
Generic Name: Tobramycin and Dexamethasone
Package Contents: 0.3%, 0.1%
Storage Requirements: Room Temperature (2℃~25℃)
Main Usage:

Here to help

Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager

International Shipping

Seamless delivery across the world

Easy Returns

Flexible solutions with our 30 day return policy

Secure Payments

Order confidently with private security network